EU approves Gilead’s new injection for preventing HIV
By Deena Beasley (Reuters) -The European Commission has granted marketing authorization for Gilead Sciences’ twice-yearly injection for preventing HIV infection, the company said on Tuesday. The drug, known scientifically as lenacapavir, will be sold in Europe under the brand name Yeytuo. It was approved in June by regulators in the U.S., where it is marketed …
EU approves Gilead’s new injection for preventing HIV Read More »








